Muscular Development magazine has a fairly lengthy article this month on melanotan I and melanotan II with a mention of Scenesse.
Tanning is a top life priority for the muscle heads.
Nothing in the article that is new, but to the author's credit, overall he did a pretty good job with the article. And he did warn about the dangers of the unregulated peptides sold on the i-Net...which surprised me given that rag has tons of ads for unproven supplements.
The significance of the article is the media coverage, which might have some of their readers Googling 'Scenesse.'
Not exactly the Wall Street Journal, but it's coverage anyway.
- Forums
- ASX - By Stock
- CUV
- muscle mag article
muscle mag article
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.09 |
Change
0.100(0.71%) |
Mkt cap ! $705.3M |
Open | High | Low | Value | Volume |
$14.00 | $14.30 | $13.93 | $676.4K | 47.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200 | $14.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.16 | 405 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 14.040 |
1 | 150 | 13.920 |
2 | 6000 | 13.900 |
1 | 527 | 13.890 |
2 | 728 | 13.850 |
Price($) | Vol. | No. |
---|---|---|
14.290 | 709 | 1 |
14.300 | 833 | 1 |
14.430 | 668 | 1 |
14.460 | 709 | 1 |
14.490 | 180 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CUV (ASX) Chart |